Company news

Botanix Pharmaceuticals Limited news in 2021

Botanix Pharmaceuticals Limited's news releases, calls and decks from 2021, newest first.

View company

Canine Atopic Dermatitis Program Launched

September 28, 2021

Final Report and Annual Report to Shareholders

August 26, 2021

New Canine Pilot Study Supports Further AD Investigation

May 16, 2021

Botanix Update on BTX 1801 Clinical Development

May 3, 2021

BTX 1702 Rosacea Study Approval

March 29, 2021

Botanix receives A$6.87m R&D Tax Incentive Refund

February 11, 2021

Phase 2a Study Shows BTX 1801 Eradicates S. Aureus

February 2, 2021

Antimicrobial Data Published in Peer-Reviewed Journal

January 19, 2021

Decks in 2021